• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DEPTOR 抑制垂体腺瘤细胞增殖,并增加对多巴胺激动剂的敏感性。

DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.

机构信息

Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Medicinal Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Cancer Lett. 2019 Sep 10;459:135-144. doi: 10.1016/j.canlet.2019.05.043. Epub 2019 Jun 6.

DOI:10.1016/j.canlet.2019.05.043
PMID:31176743
Abstract

DEP domain-containing mechanistic target of rapamycin (mTOR)-interacting protein (DEPTOR) is an important modulator of mTOR, a highly conserved kinase whose hyperactivation is critically involved in a variety of human tumors. The role of DEPTOR playing in pituitary adenoma (PA) is largely unknown. Here, we reported that DEPTOR was downregulated in PA tissues, especially dopamine-resistant prolactinomas. Consistently, overexpression of DEPTOR inhibited pituitary tumor GH3 and MMQ cells proliferation in vitro and in vivo, and sensitized GH3 and MMQ cells to cabergoline (CAB), a dopamine agonist (DA). Conversely, knockdown of DEPTOR promoted GH3 and MMQ cells proliferation, and conferred cells resistance to CAB. Mechanistically, DEPTOR inhibited both mTOR Complex 1 (mTORC1) and 2 (mTORC2) activities in PA cells. In addition, DEPTOR expression level was increased to suppress mTOR kinase activity via decreasing E3 ubiquitin ligase, βTrCP1, in response to CAB. Furthermore, DEPTOR enhanced autophagy-dependent cell death to confer cells sensitivity to CAB. Taken together, our results suggest that DEPTOR may be a potential target for the treatment of PAs.

摘要

DEP 结构域含有机械靶标雷帕霉素(mTOR)相互作用蛋白(DEPTOR)是 mTOR 的重要调节剂,mTOR 是一种高度保守的激酶,其过度激活与多种人类肿瘤密切相关。DEPTOR 在垂体腺瘤(PA)中的作用在很大程度上是未知的。在这里,我们报道 DEPTOR 在 PA 组织中下调,特别是多巴胺耐药的泌乳素瘤。一致地,DEPTOR 的过表达抑制了体外和体内垂体瘤 GH3 和 MMQ 细胞的增殖,并使 GH3 和 MMQ 细胞对卡麦角林(CAB)敏感,CAB 是一种多巴胺激动剂(DA)。相反,DEPTOR 的敲低促进了 GH3 和 MMQ 细胞的增殖,并赋予了细胞对 CAB 的耐药性。在机制上,DEPTOR 抑制了 PA 细胞中的 mTOR 复合物 1(mTORC1)和 2(mTORC2)的活性。此外,DEPTOR 的表达水平增加,通过减少 E3 泛素连接酶βTrCP1,以响应 CAB 来抑制 mTOR 激酶活性。此外,DEPTOR 增强了自噬依赖性细胞死亡,使细胞对 CAB 敏感。总之,我们的结果表明 DEPTOR 可能是治疗 PA 的潜在靶点。

相似文献

1
DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.DEPTOR 抑制垂体腺瘤细胞增殖,并增加对多巴胺激动剂的敏感性。
Cancer Lett. 2019 Sep 10;459:135-144. doi: 10.1016/j.canlet.2019.05.043. Epub 2019 Jun 6.
2
The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.KBTBD6/7-DRD2 轴调节垂体腺瘤对多巴胺激动剂治疗的敏感性。
Acta Neuropathol. 2020 Sep;140(3):377-396. doi: 10.1007/s00401-020-02180-4. Epub 2020 Jun 22.
3
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists.长链非编码 RNA-H19/miRNA-93a/ATG7 轴调控垂体腺瘤对多巴胺激动剂的敏感性。
Mol Cell Endocrinol. 2020 Dec 1;518:111033. doi: 10.1016/j.mce.2020.111033. Epub 2020 Sep 15.
4
Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR.磷酸化蛋白质组分析揭示雌激素-ER 途径通过 DEPTOR 调节 mTOR 活性。
Mol Cell Proteomics. 2019 Aug;18(8):1607-1618. doi: 10.1074/mcp.RA119.001506. Epub 2019 Jun 12.
5
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.丝裂原活化蛋白激酶 11/12/13/14(p38MAPK)蛋白在多巴胺激动剂抵抗性泌乳素瘤中的作用。
BMC Endocr Disord. 2021 Nov 23;21(1):235. doi: 10.1186/s12902-021-00900-9.
6
Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine.卡麦角林与氯喹联合抑制垂体瘤。
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3692-3703. doi: 10.1210/jc.2017-00627.
7
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.溴隐亭和卡麦角林分别通过 ERK/EGR1 和 AKT/mTOR 通路诱导泌乳素瘤细胞死亡。
Cell Death Dis. 2019 Apr 18;10(5):335. doi: 10.1038/s41419-019-1526-0.
8
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.卡麦角林对mTOR通路的抑制及自噬依赖性细胞死亡的诱导作用
Oncotarget. 2015 Nov 17;6(36):39329-41. doi: 10.18632/oncotarget.5744.
9
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.ACT001 通过 AMPK 介导的 EGR1 和 mTOR 通路逆转催乳素瘤的耐药性。
Endocr Relat Cancer. 2021 Dec 13;29(2):33-46. doi: 10.1530/ERC-21-0215.
10
DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis.血管内皮细胞中DEPTOR缺陷介导的mTORc1过度激活促进血管生成。
Cell Physiol Biochem. 2018;46(2):520-531. doi: 10.1159/000488619. Epub 2018 Mar 26.

引用本文的文献

1
Targeting Autophagy for Pituitary Tumors.针对垂体肿瘤的自噬作用
Cancers (Basel). 2025 Apr 23;17(9):1402. doi: 10.3390/cancers17091402.
2
Cabergoline-induced NDFIP1 upregulation in pituitary neuroendocrine tumor cells activates mTOR signaling and contributes to cabergoline resistance.卡麦角林诱导垂体神经内分泌肿瘤细胞中NDFIP1上调,激活mTOR信号通路并导致卡麦角林耐药。
J Neurooncol. 2025 May;172(3):587-597. doi: 10.1007/s11060-025-04949-7. Epub 2025 Feb 1.
3
Ubiquitination regulates autophagy in cancer: simple modifications, promising targets.
泛素化调节癌症中的自噬:简单的修饰,有前途的靶点。
J Transl Med. 2024 Oct 31;22(1):985. doi: 10.1186/s12967-024-05565-1.
4
Identification and Validation of Genes Related to Macrophage Polarization and Cell Death Modes Under Infection.感染状态下与巨噬细胞极化及细胞死亡模式相关基因的鉴定与验证
J Inflamm Res. 2024 Feb 29;17:1397-1411. doi: 10.2147/JIR.S448372. eCollection 2024.
5
Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis.Sestrin2 通过抑制代谢相关脂肪性肝炎中 RIPK3 介导的坏死性凋亡来维持肝脏免疫稳态和氧化还原平衡。
Mol Metab. 2024 Feb;80:101865. doi: 10.1016/j.molmet.2023.101865. Epub 2023 Dec 30.
6
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.侵袭性 PitNETs 及潜在的靶向治疗:分子和遗传途径的系统综述。
Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719.
7
The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.UBE2C/CDH1/DEPTOR 轴是肺癌细胞中的癌基因和肿瘤抑制子级联。
J Clin Invest. 2023 Feb 15;133(4):e162434. doi: 10.1172/JCI162434.
8
DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.DFNA5 通过上调 DEPTOR 抑制 mTORC1/2 信号通路抑制结直肠癌细胞增殖。
Cell Cycle. 2022 Oct;21(20):2165-2178. doi: 10.1080/15384101.2022.2088570. Epub 2022 Aug 3.
9
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT.TRIM65 通过泛素化和降解 TPIT 决定新型垂体神经内分泌肿瘤的命运。
Neuro Oncol. 2022 Aug 1;24(8):1286-1297. doi: 10.1093/neuonc/noac053.
10
N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.N6-甲基腺苷相关长非编码 RNA 是肿瘤微环境中潜在的重构指标和骨肉瘤的预后标志物。
Front Immunol. 2022 Jan 12;12:806189. doi: 10.3389/fimmu.2021.806189. eCollection 2021.